The Indian drug landscape presents a complex picture, increasingly characterized by fears surrounding monopolistic practices. While the country is lauded as a global drug powerhouse and a crucial supplier of affordable medicines, a growing number of experts are highlighting the tendency for a few large corporations to command significant market seg

India's pharmaceutical landscape presents a complex picture, largely shaped by the substantial influence of a few prominent players. While the sector website is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of market concentration that warrants scrutiny. These incumbent companies, including orga